Improvement in Baroreflex Sensitivity in OSAS

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2005 by Nagoya University.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Nagoya University

ClinicalTrials.gov Identifier:

NCT00284037

First received: January 27, 2006

Last updated: NA

Last verified: May 2005

History: No changes posted

Tracking Information

First Received Date ^ICMJE

January 27, 2006

Last Updated Date

January 27, 2006

Start Date ^ICMJE

Not Provided

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Improvement in Baroreflex Sensitivity in OSAS

Official Title ^ICMJE

Not Provided

Brief Summary

Individuals with obstructive sleep apnea syndrome (OSAS) are at high risk for cardiovascular morbidity and mortality. The effect of long-term nocturnal therapy with continuous positive airway pressure (CPAP) on daytime baroreflex sensitivity (BRS), a predictor of cardiac death, was investigated in OSAS patients.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Condition ^ICMJE

Obstructive Sleep Apnea Syndrome

Intervention ^ICMJE

Device: continuous positive airway pressure therapy

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

obstructive sleep apnea syndrome

Exclusion Criteria:

diabetes mellitus, chronic obstructive lung disease, coronary or valvular heart disease, congestive heart failure, renal failure, or endocrine dysfunction. Moreover, none of them were taking b-blockers, vasodilators, or inotropic agents at the time of enrollment in the study.

Gender

Both

Ages

20 Years to 70 Years

Accepts Healthy Volunteers

Not Provided

Contacts ^ICMJE

Contact: Akiko Noda, PhD

+81-52-719-1537

a-noda@met.nagoya-u.ac.jp

Location Countries ^ICMJE

Japan

Administrative Information

NCT Number ^ICMJE

NCT00284037

Other Study ID Numbers ^ICMJE

NU-06-A-0003

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Nagoya University

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Chair:

Mitsuhiro Yokota, MD.PhD

Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya, Aichi, Japan

Information Provided By

Nagoya University

Verification Date

May 2005

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top